Day-to-day health care given by a health care provider
POPULARITY
Categories
708 episodes with Primary care
432 episodes with Primary care
299 episodes with Primary care
203 episodes with Primary care
193 episodes with Primary care
234 episodes with Primary care
103 episodes with Primary care
72 episodes with Primary care
72 episodes with Primary care
49 episodes with Primary care
158 episodes with Primary care
58 episodes with Primary care
27 episodes with Primary care
49 episodes with Primary care
31 episodes with Primary care
38 episodes with Primary care
35 episodes with Primary care
28 episodes with Primary care
64 episodes with Primary care
33 episodes with Primary care
53 episodes with Primary care
23 episodes with Primary care
35 episodes with Primary care
27 episodes with Primary care
20 episodes with Primary care
81 episodes with Primary care
26 episodes with Primary care
36 episodes with Primary care
31 episodes with Primary care
24 episodes with Primary care
27 episodes with Primary care
18 episodes with Primary care
26 episodes with Primary care
20 episodes with Primary care
28 episodes with Primary care
33 episodes with Primary care
16 episodes with Primary care
23 episodes with Primary care
15 episodes with Primary care
15 episodes with Primary care
14 episodes with Primary care
15 episodes with Primary care
31 episodes with Primary care
34 episodes with Primary care
31 episodes with Primary care
14 episodes with Primary care
27 episodes with Primary care
22 episodes with Primary care
23 episodes with Primary care
28 episodes with Primary care
265 episodes with Primary care
16 episodes with Primary care
15 episodes with Primary care
10 episodes with Primary care
Limiting the side effects of cancer treatments has been an animating force in the field of oncology for many years, and there's been progress to report on that front, but what if you could target cancer tumors without using radiation or chemotherapy and instead generate heat from inside the tumor to kill cells? That's the quest of our guest today, Dr. Hadiyah-Nicole Green, whose promising research using lasers and nanoparticles to eliminate tumors received Breakthrough Device Designation from the FDA earlier this year. “The laser beam that we're using is low power like a laser pointer, and without activation by the laser, the nanoparticles are harmless. Both are targeted just at the site of the tumor so because we don't use systemic delivery, we avoid all of the systemic side effects,” she explains.Dr. Green is also the founder and president of the Ora Lee Smith Cancer Research Foundation, named for an aunt who raised her and who died of cancer without pursuing curative treatment because of her fear of the side effects. Shortly after, her aunt's husband also died of cancer, opting for treatments that took a heavy toll on his body. “At 22 years old, I saw the horrors of cancer and the horrors of cancer treatment and just felt in my heart that there has to be something better than this,” she tells host Michael Carrese.On this fascinating episode of Raise the Line from Elsevier, we'll explore the science behind Dr. Green's approach, the challenges of raising the millions of dollars needed for human clinical trials, and rethinking the current funding landscape for cancer treatments.Mentioned in this episode:Ora Lee Smith Cancer Research Foundation If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast
This week, we feature new research on colorectal cancer surveillance, metabolic acidosis in critical illness, pediatric leukemia, and food-allergy prevention. We also review esophageal cancer and follow a case of severe nutritional deficiency and memory loss. Perspectives address AI and the clinical workforce, physician staffing in the Indian Health Service, human trafficking and child health, and the enduring legacy of the HIV epidemic.
In this episode, Lori Feldman-Winter, MD, MPH, FAAP, discusses how pediatricians can reduce racial disparities in breastfeeding. David Hill, MD, FAAP, and Joanna Parga-Belinkie, MD, FAAP, also speak with Alexander Fiks, MD, FAAP, and Kristin Ray, MD, MS, FAAP, about telemedicine use in primary care for children. For resources go to aap.org/podcast.
Dr. Centor discusses the revitalization of primary care internal medicine with Drs. Sara Fazio and Kelly Graham.
In this episode, Paul Battle, President and Co-Founder, Medome, discusses using AI to reduce misdiagnosis, transform primary care and enable more proactive, personalized healthcare.
You're taking a GLP-1 medication, but the scale isn't moving the way you expected. Maybe you've even watched someone else say they lost 20 pounds in two months and wondered, "Why isn't this working for me?" If you've been asking yourself that question, I want you to know that your experience with a GLP-1 medication may look very different from someone else's. In this episode, I'm breaking down four reasons you may not be losing as much weight as you expected on a GLP-1, and what I look at when a patient tells me their medication isn't working. I'll also talk about something that can easily get lost when we compare our weight loss journey to what we see on social media. Before you decide that your GLP-1 has failed, there are some important questions to consider. Your dose, your overall health habits, your nutrition, and your treatment plan can all be part of the bigger picture. If you're frustrated by slow weight loss on a GLP-1, listen to this episode before you assume you're doing something wrong. Episode Highlights: Why your weight loss may not look like someone else's, even when you're taking the same type of medication What I look at when a patient feels their GLP-1 isn't working When your dose may be part of the picture Why nutrition and lifestyle still matter during GLP-1 treatment A question you may not expect to ask when your appetite has changed When it may be time to reassess your treatment plan Why comparing your progress to someone on social media can be misleading The mindset I want you to have when your weight loss isn't moving as quickly as you hoped Connect with Dr. Alicia Shelly Website | drshellymd.com Facebook | www.facebook.com/drshellymd Instagram | @drshellymd Linked In | www.linkedin.com/in/drshellymd Twitter | @drshellymd About Dr. Alicia Shelly Dr. Alicia Shelly was raised in Atlanta, GA. She received her Doctorate of Medicine from Case Western Reserve University School of Medicine in Cleveland, OH. Dr. Shelly has been practicing Primary Care and Obesity medicine since 2014. In 2017, she became a Diplomat of the American Board of Obesity Medicine. She is the lead physician at the Wellstar Medical Center Douglasville. She started a weekly podcast & Youtube channel entitled Back on Track: Achieving Healthy Weight loss, where she discusses how to get on track and stay on track with your weight loss journey. She has spoken for numerous local and national organizations, including the Obesity Medicine Association, and the Georgia Chapter of the American Society of Metabolic and Bariatric Surgeons. She has been featured on CNN, Fox 5 News, Bruce St. James Radio show, Upscale magazine, and Shape.com. She was named an honoree of the 2021 Atlanta Business Chronicle's 40 under 40 award. She also is a collaborating author for the, "Made for More: Physician Entrepreneurs who Live Life and Practice Medicine on their own terms''. Resources: FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!)
Most healthcare organizations know specialty care matters. Almost none of them are actually using it at the level their patients need.In this episode of The Disrupted Podcast, Jamie Preston sits down with Scott Middleton — Founder and Chief Disruption Officer of Your Health — for an unfiltered look at one of the most critical gaps in care delivery: specialty services. Your Health currently routes about 10% of its patient appointments through specialty providers. The national average is 20%. Scott makes the case — with real stories from nursing homes, lawsuits, and the road across South Georgia — that closing that gap isn't just a clinical priority, it's a survival strategy.What you'll hear in this episode:Why a 400-pound patient in a nursing home had never been offered a GLP-1 for weight loss — and what that reveals about how providers think about specialtyThe exact communication chain (DPH → EDCS → Care Manager → Provider) and precisely where it breaks downHow 80% of Your Health patients have behavioral health needs while psych providers sit with open schedules — and how to fix that paradoxWhy texts and emails don't cut it in care coordination — and why voice-to-voice is the only real standardThe lawsuit that should have been prevented with a single chest x-ray, and what it means for provider accountability going forwardWhy Scott banned the word "no" inside Your Health — and the mindset shift that comes with replacing itSpecialty is what separates Your Health from every other provider in the market. If you're a DPH, a care manager, or a provider inside this system — this episode is for you. If you're a healthcare leader watching specialty care fall through the cracks anywhere, it might be for you too. www.YourHealth.Org
"It's really hard to justify a test that has any complications if there isn't any reasonable expectation of benefit," says Dr. Rita Redberg, who has spent her career trying to help fellow clinicians consider the actual value of routine screenings and diagnostic testing in asymptomatic patients. Dr. Redberg -- a cardiologist and professor of medicine at the University of California, San Francisco for more than three decades -- is one of the leading voices advocating for a “high-value care” approach, an uphill fight in a healthcare system that tends to reward action over restraint. Her highest profile effort was launching the instructive “Less is More” series in JAMA Internal Medicine when she served as its editor-in-chief for 14 years. On a related track, her research on the assessment of the safety and effectiveness of medical technology, specifically high-risk cardiovascular devices, has yielded a troubling picture. "We found only 1% of devices enter the market through the FDA's most rigorous approval process. The high-quality evidence to support benefit for these devices that I had assumed was present, wasn't actually there.” Join Raise the Line host Lindsey Smith for an eye-opening exploration of what Dr. Redberg considers to be the overlooked risks and false reassurance of common tests and procedures, and her efforts to put the “do no harm” principle of medicine at the forefront of everyday practice.Mentioned in this episode:UCSF School of MedicineJAMA Internal Medicine's Less is More Series If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast
Private Equity in Primary Care: Just Another Inflationary Business Model? What Does the Data Actually Show, With Yashaswini Singh, PhD (EP528) Private equity has been buying up primary care practices for years, promising the capital that chronically underfunded clinicians badly need. But does the money actually make care better? Yashaswini Singh, PhD, MPA, the Thomas J. and Alice M. Tisch Assistant Professor of Health Services, Policy, and Practice at Brown University, has spent years studying that question — and her newest research, published in Health Affairs and JAMA Health Forum, finds PE-affiliated primary care physicians negotiate prices 8% to 10% higher than independent doctors, while patient outcomes barely budge. WHAT YOU'LL LEARN ✅ Why negotiated prices for PE-affiliated primary care physicians run 8% to 10% higher than independent doctors — and why hospital-affiliated physicians still command the highest prices of all ✅ How a national study of roughly 200 PE-acquired primary care practices found a 20% increase in preventive services, including the Medicare Annual Wellness Visit, with no evidence of low-value care ✅ Why "cognitive atrophy" — deskilling from rigid, box-checking visits — isn't inevitable under PE ownership, but why the "best case scenario" often isn't what's actually happening ✅ How opaque common ownership — the same investors owning primary care, GI, orthopedic, and oncology practices — can create hidden referral incentives current data can't detect ✅ Why site-of-care payment arbitrage — a hospital-owned MRI can cost double or triple an independent one — drives referral-machine incentives regardless of who owns the practice ✅ Why PE's promise to reduce fragmentation through consolidation has instead produced physician turnover that undermines the patient-doctor relationship WHY THIS MATTERS Primary care clinicians are chronically underpaid, and private equity promises the capital to fix that. But Dr. Singh's research shows a real tradeoff: costs rise 8% to 10% while quality barely moves. Whether professional capital builds sustainable, whole-person care or becomes, as Stacey puts it, corporate arbitrage in a different Halloween costume depends on realigning payment incentives around outcomes rather than throughput — something no ownership model, PE included, is yet built to do. MENTIONED IN THIS EPISODE EP519 with Lisa Rosenbaum, MD: Apple Podcasts | Spotify | Other Apps LinkedIn Post by Yashaswini Singh, PhD EP474 with Yashaswini Singh, PhD: Apple Podcasts | Spotify | Other Apps Study: "Private Equity Acquisitions in Primary Care" (Health Affairs) Study: "Private Equity Acquisition in Primary Care and Avoidable Hospitalizations" (JAMA Health Forum) LinkedIn Comment by Andrea DeSantis, DO, FAAFP EP521 with Andrew Tsang: Apple Podcasts | Spotify | Other Apps EP523 with Suhas Gondi, MD, MBA: Apple Podcasts | Spotify | Other Apps === LINKS ===
This week, we feature new research on gene-edited therapies for children with β-thalassemia and sickle cell disease, treatment for membranous nephropathy, coronary revascularization after myocardial infarction, and an outbreak of severe methemoglobinemia. We review treatment decisions in multiple myeloma, follow a case of man with fever and rash, and report on psychedelic drug development. Perspectives address preventive care, AI-assisted translation, barriers to health care access, and the long shadow of Bedlam.
Fifteen minutes. That's about all the time most pediatricians have to care for an entire child and family. In that brief visit, they are expected to address preventive care, developmental concerns, chronic conditions, behavioral health, documentation, and countless questions from parents, all while building meaningful relationships. It's a lot to ask of both clinicians and the healthcare system. What if the answer isn't working faster, but working differently? Today, we're talking about how pediatric practices can build systems that support better coordinated, family-centered care while creating more sustainable and fulfilling careers for clinicians. Joining us for this important discussion is Tricia Ramos, MD. She is a general pediatrician visiting all the way from Quezon City in the Philippines. Some highlights from this episode include: How to balance family's needs and pediatricians' priorities in a short visit Biggest pain points in today's pediatric practices Systems and workflows that have made a meaningful difference in improving care High-impact changes smaller or independent clinics can implement For more information on Children's Colorado, visit: childrenscolorado.org.
Have you ever wondered whether compounded GLP-1 medications are as safe and effective as brand-name medications? Or how you can tell if a GLP-1 or peptide product is fake? In this episode of Back on Track: Achieving Healthy Weight Loss, I'm continuing my Ask the Obesity Doctor series, where I answer real questions you've left on my YouTube videos and social media. This time, I'm talking about safety. I'll answer five questions about compounded GLP-1 medications, counterfeit and black-market products, medication interactions, side effects, and something I hear frequently from patients: "Ozempic face." I'll explain the difference between brand-name and compounded medications and why compounded medications have not gone through the same rigorous testing as brand-name medications. I'll also talk about why you can't reliably tell whether a GLP-1 or peptide product purchased from the black market is authentic or counterfeit. I'll discuss medication combinations that require extra caution when taking GLP-1 medications, including oral birth control and warfarin, and what you should do if you experience symptoms that concern you. Finally, I'll explain what people mean when they talk about "Ozempic face," why it doesn't happen to everyone, and why you shouldn't assume your experience with a GLP-1 medication will be the same as someone else's. These are questions I hear frequently, and my goal is to help you better understand what to discuss with your own healthcare provider. This episode is for education only and is not a substitute for personalized medical advice. Episode Highlights: The difference between brand-name and compounded GLP-1 medications Why compounded medications have not gone through the same rigorous testing as brand-name medications Why you cannot reliably tell if a black-market GLP-1 or peptide product is authentic Why I recommend avoiding counterfeit and black-market peptide products Medication combinations that require extra caution when taking GLP-1 medications What to do if you experience unusual or concerning side effects What "Ozempic face" actually means and why it doesn't happen to everyone Why you should not compare your GLP-1 experience to someone else's If you haven't listened to Part 1 yet, I recommend starting there and then continuing with this episode for the second set of questions. Listen to Part 1: #254: Ask the Obesity Doctor Part 1: GLP-1, Contrave, Thyroid, Dosing & Calories https://bit.ly/BackOnTrackEpisodes If you're using a GLP-1 medication, considering one, or simply trying to understand the information you're seeing online, I hope this episode helps you have a more informed conversation with your healthcare provider. Connect with Dr. Alicia Shelly Website | drshellymd.com Facebook | www.facebook.com/drshellymd Instagram | @drshellymd Linked In | www.linkedin.com/in/drshellymd Twitter | @drshellymd About Dr. Alicia Shelly Dr. Alicia Shelly was raised in Atlanta, GA. She received her Doctorate of Medicine from Case Western Reserve University School of Medicine in Cleveland, OH. Dr. Shelly has been practicing Primary Care and Obesity medicine since 2014. In 2017, she became a Diplomat of the American Board of Obesity Medicine. She is the lead physician at the Wellstar Medical Center Douglasville. She started a weekly podcast & Youtube channel entitled Back on Track: Achieving Healthy Weight loss, where she discusses how to get on track and stay on track with your weight loss journey. She has spoken for numerous local and national organizations, including the Obesity Medicine Association, and the Georgia Chapter of the American Society of Metabolic and Bariatric Surgeons. She has been featured on CNN, Fox 5 News, Bruce St. James Radio show, Upscale magazine, and Shape.com. She was named an honoree of the 2021 Atlanta Business Chronicle's 40 under 40 award. She also is a collaborating author for the, "Made for More: Physician Entrepreneurs who Live Life and Practice Medicine on their own terms''. Resources: FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!)
Dr. Sarai Ambert-Pompey opened Libélula Primary Care in Boise, Idaho. "Libélula" is Spanish for dragonfly, chosen for transformation. One year in, she joins Dr. Maryal Concepcion to talk about what changed when she left the VA for Direct Primary Care.Her path is unconventional: CompUSA and GameStop, Sony PlayStation reviewer training, oncology research at OHSU, then internal medicine residency in Boise. At the VA she joined a Primary Care Center of Excellence and helped launch the Boise Clinical Resource Hub, delivering clinic-to-clinic telehealth to rural sites across the Northwest, then trained physicians in telemedicine through the Ada County Medical Society during the pandemic.In this episode:Why time is the intervention - patients arrive never having been told their A1C goal, their blood pressure goal, or what their medications are for. Longer visits keep high ER utilizers out of the ER.Culturally responsive care in Idaho - Boise is predominantly white, but farming communities and employers like Micron bring diversity the traditional system was never built to serve. Healthcare trauma can take several visits to overcome before a patient consents to a blood draw.Telehealth done right - her top three: screen whether the visit is appropriate, build an emergency protocol and know your state's consent law, and actually perform a physical exam on video. Most clinicians skip that last one.How to vet an EHR - test customer service response time first, ask about interoperability, run a full patient walkthrough instead of the salesperson's highlight reel, get pricing broken out line by line, ask how an AI scribe stores data, and watch for 12-month contracts.Community as marketing - she launched a Walk with a Doc chapter before the clinic opened. Chamber involvement, immigration medical exams, and one paid social promo that returned its investment in a week.Leaving the system - 15 pounds lost, sleep restored, weekends back. "I tell anyone who will listen: I wish I had done it earlier."Mentioned: IN -PERSON DPC SUMMIT COMING IN OCT 2026! Illinois DPC Summit, first week of October, open to out-of-state physicians - register at caradirectcare.com/summit · Walk with a Doc · Latino Conservation Week · Idaho Hispanic Chamber of CommerceFree DPC startup checklist, the Physician Owner's Planner, and the DPC Toolkit Magazine: mydpcstory.com Leave a voice message for the show: mydpcstory.com/contact Follow @mydpcstory · Leave a 5-star review on Apple PodcastsCONGRATULATIONS Dr. Oropeza!!!! Learn more about Oropeza Family Health at https://oropezahealth.com/ Get your copy of the Physician Owner's Planner today at mydpcstory.com/library Learn more about Hint Summit at: https://go.hint.com/45zknvf Support the showGET your FREE MONTHLY BUSINESS TOOL DOWNLOADBecome A My DPC Story PATREON MEMBER! SPONSOR THE PODMy DPC Story VOICEMAIL! DPC SWAG!FACEBOOK * INSTAGRAM * LinkedIn * TWITTER * TIKTOK * YouTube
Send us Fan MailAmerican healthcare still runs on fax machines, paper forms, and reimbursement models built for reactive sick care. Meanwhile, patients are connecting wearables to AI chatbots, ordering their own labs, and triaging themselves without ever seeing a physician.Dr. Daniel Kraft, Founder of Digital.Health and NextMed Health, joins host John Driscoll to discuss why the consumer is pulling healthcare into the future faster than institutions can follow, and what continuous, AI-powered, multimodal health monitoring could mean for the 500 million people who cannot get timely access to a primary care doctor today.
The next few months might be an inflection point for GPs in England and Wales Our strong primary care system is often credited in the success of the NHS - But changes to how that system works are currently underway. Legislation is quietly proceeding through parliament that will reorganise the way in which local care is structured, and those changes are raising concerns for GPs. To talk about how we build a stronger primary care system, and stronger NHS we're joined by: Victoria Tzortziou Brown, president of the Royal College of General Practitioners Sam Everington, a GP in East London, and a non-executive director of NHS England Kamila Hawthorne, GP in South Wales, and chair of National Academy for Social Prescribing We also take the opportunity to hear about where social prescribing fits into this new picture, and why our panel think it's important in changing the UK's health. Reading list Building a stronger NHS: an open letter from past and present presidents and chairs of the Royal College of General Practitioners
Credits: 0.75 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-500 Overview: To celebrate our 500th episode, each member of our team revisits a popular topic from the podcast's earlier installments—GLP-1s, cervical and breast cancer screening, diet and exercise, contraception, hypertension, and lipid management—to trace how the evidence and guidelines have changed since it was first covered. Whether you're catching up or reinforcing what you know, this milestone episode helps you bring the latest evidence into everyday patient care. Guest: Robert Baldor, MD, Alan Ehrlich, MD, Susan Feeney, DNP, FNP-BC; FAANP, Jillian Joseph, PA, Mariyan L. Montaque, DNP, FNP-BC, Jill Terrien PhD, ANP-BC, FAAN Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com Episode resource links: Zhou H et al. Evaluation and Comparison of the PREVENT and Pooled Cohort Equations for 10‐Year Atherosclerotic Cardiovascular Risk Prediction. Journal of the American Heart Association Volume 14, Number 4 Goff DC et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation. 2014;129:S49–S73. Circulation. 2018 Jul 24;138(4):345-355. eClinicalMedicine 2025: 103741. Curry, J. (2018). Screening for cervical cancer: US Preventive Services Task Force Recommendation Statement. JAMA.320(7):674-686. doi:10.1001/jama.2018.10897 https://www.ncbi.nlm.nih.gov/pubmed/30140884 Perkins RB, Wolf AMD, Church TR, et al. Self-collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline. CA Cancer J Clin. 2026;e70041. doi:10.3322/caac.70041 Screening for Cervical Cancer (2026). Obstetrics & Gynecology, 148(1), e63-e67. https://doi.org/10.1097/AOG.0000000000006257 Jad Zeitouni, Nosayaba Osazuwa-Peters, Yusuf Dundar, Gregory Zimet, Mark A. Varvares. (2025). Two decades of the HPV vaccine: its promise, progress, prospects, projections, and posterity, The Lancet Regional Health - Americas, (51), https://doi.org/10.1016/j.lana.2025.101243 Diabetes, Obesity and Metabolism 28, no. 6 (2026): 5043–5057, https://doi.org/10.1111/dom.70698. Relationship of early rapid weight loss to efficacy and safety of tirzepatide and semaglutide for obesity: SURMOUNT-5 post hoc analysis. Am J Med. 2026 Jul;139(7):913-921. doi: 10.1016/j.amjmed.2026.03.010 US Preventive Services Task Force; Nicholson WK, Silverstein M, Wong JB, et al. Screening for breast cancer: US Preventive Services Task Force recommendation statement. JAMA. 2024;331(22):1918–1930. Trentham-Dietz A, Chapman CH, Jayasekera J, et al. Collaborative modeling to compare different breast cancer screening strategies: a decision analysis for the US Preventive Services Task Force. JAMA. 2024;331(22):1931–1946. Giaquinto AN, Sung H, Miller KD, et al. Breast cancer statistics, 2022. CA Cancer J Clin. 2022;72(6):524–541. Qaseem A, Harrod CS, Balk EM, et al. Screening for breast cancer in asymptomatic, average-risk adult females: a guidance statement from the American College of Physicians (Version 2). Ann Intern Med. 2026.: American Cancer Society. Breast Cancer Facts & Figures 2022–2024. Atlanta, GA: American Cancer Society, 2022. Hu X, Chehal PK, Kaplan C, et al. Racial differences in patient-reported symptoms and adherence to adjuvant endocrine therapy among women with early-stage, hormone receptor-positive breast cancer. JAMA Netw Open. 2022;5(8):e2225485. Torres JM, Sodipo MO, Hopkins MF, Chandler PD, Warner ET. Racial differences in breast cancer survival between Black and White women according to tumor subtype: a systematic review and meta-analysis. J Clin Oncol. 2024;42(35):4225–4234. Bailey ZD, Krieger N, Agénor M, Graves J, Linos N, Bassett MT. Structural racism and health inequities in the USA: evidence and interventions. Lancet. 2017;389(10077):1453–1463. Hypertension. 2026;83:00–00. DOI: 10.1161/HYPERTENSIONAHA.125.25787 Allen RH, Bartz D. Opill: The Over-the-Counter Contraceptive Pill. Obstet Gynecol. 2024;143(2):184-188. doi:10.1097/AOG.0000000000005455 Cahill EP, Kaur S. Advances in contraception research and development. Curr Opin Obstet Gynecol. 2020;32(6):393-398. doi:10.1097/GCO.0000000000000666 Charles DN, Nagarsheth M, Oshman L. Pain Management for IUD Insertion in Primary Care. Am Fam Physician. 2025;111(4):299-301. Chen, C., Strasser, J., Banawa, R., Luo, Q., Bodas, M., Castruccio-Prince, C., Das, K., & Pittman, P. (2022). Who is providing contraception care in the United States? An observational study of the contraception workforce. American journal of obstetrics and gynecology, 226(2), 232.e1–232.e11. https://doi.org/10.1016/j.ajog.2021.08.015 Diedrich,J., Klein, D. Peipert, J.(2017). Long-acting reversible contraception in adolescents: a systematic review and meta-analysis, Am J Ob Gyn, April 2017. http://dx.doi.org/10.1016/j.ajog.2016.12.024 Li RHW, Lo SST, Gemzell-Danielsson K, Fong CHY, Ho PC, Ng EHY. Oral emergency contraception with levonorgestrel plus piroxicam: a randomised double-blind placebo-controlled trial. Lancet. 2023;402(10405):851-858. doi:10.1016/S0140-6736(23)01240-0 Mørch LS, Meaidi A, Corn G, Hargreave M, Wessel Skovlund C. Breast Cancer in Users of Levonorgestrel-Releasing Intrauterine Systems. JAMA. 2024;332(18):1578–1580. doi:10.1001/jama.2024.18575 Nguyen AT, Curtis KM, Tepper NK, et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. MMWR Recomm Rep. 2024;73(4):1-126. Published 2024 Aug 8. doi:10.15585/mmwr.rr7304a1 Paradise SL, Landis CA, Klein DA. Evidence Based Contraception: Common Questions and Answers. American Family Physician. 2022. https://www.aafp.org/afp/2022/0900/contraception The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.
For millions of young women and girls, often the first place they turn with questions about their bodies isn't a doctor's office, it's social media which can lead to encountering many misconceptions and outright misinformation. Or, if the right voices show up, it can mean something else entirely. Our guest today, Dr. Charis Chambers, is one of those voices. She's a board-certified OB/GYN with specialty certification in Pediatric & Adolescent Gynecology, and Chief Medical Officer at Clue, a leading period and cycle-tracking app. She's also the founder of The Period Doctor, a platform she launched in 2019 to provide medically accurate reproductive health information and to place more minority physicians in the spaces where patients are already looking for answers. As she tells Raise the Line from Elsevier host Lindsey Smith, Dr. Chambers embraces the role of being a bridge between generations: "I can serve as a medical mediator where I advocate for the child and then educate the parent so that the child's concerns are met." Stay tuned to this important conversation to also learn about: Her new book, The Period and Puberty Parenting Revolution, which tackles many of the same myths she encounters every day in her clinic; Why stubborn myths around periods rarely hold up once you ask where they come from; How she thinks about the responsibility, and limits, of being a trusted medical voice on social media. Mentioned in this episode: Clue The Period Doctor The Period and Puberty Parenting Revolution If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast
Credits: 0.75 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-500 Overview: To celebrate our 500th episode, each member of our team revisits a popular topic from the podcast's earlier installments—GLP-1s, cervical and breast cancer screening, diet and exercise, contraception, hypertension, and lipid management—to trace how the evidence and guidelines have changed since it was first covered. Whether you're catching up or reinforcing what you know, this milestone episode helps you bring the latest evidence into everyday patient care. Guest: Robert Baldor, MD, Alan Ehrlich, MD, Susan Feeney, DNP, FNP-BC; FAANP, Jillian Joseph, PA, Mariyan L. Montaque, DNP, FNP-BC, Jill Terrien PhD, ANP-BC, FAAN Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com Episode resource links: Zhou H et al. Evaluation and Comparison of the PREVENT and Pooled Cohort Equations for 10‐Year Atherosclerotic Cardiovascular Risk Prediction. Journal of the American Heart Association Volume 14, Number 4 Goff DC et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation. 2014;129:S49–S73. Circulation. 2018 Jul 24;138(4):345-355. eClinicalMedicine 2025: 103741. Curry, J. (2018). Screening for cervical cancer: US Preventive Services Task Force Recommendation Statement. JAMA.320(7):674-686. doi:10.1001/jama.2018.10897 https://www.ncbi.nlm.nih.gov/pubmed/30140884 Perkins RB, Wolf AMD, Church TR, et al. Self-collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline. CA Cancer J Clin. 2026;e70041. doi:10.3322/caac.70041 Screening for Cervical Cancer (2026). Obstetrics & Gynecology, 148(1), e63-e67. https://doi.org/10.1097/AOG.0000000000006257 Jad Zeitouni, Nosayaba Osazuwa-Peters, Yusuf Dundar, Gregory Zimet, Mark A. Varvares. (2025). Two decades of the HPV vaccine: its promise, progress, prospects, projections, and posterity, The Lancet Regional Health - Americas, (51), https://doi.org/10.1016/j.lana.2025.101243 Diabetes, Obesity and Metabolism 28, no. 6 (2026): 5043–5057, https://doi.org/10.1111/dom.70698. Relationship of early rapid weight loss to efficacy and safety of tirzepatide and semaglutide for obesity: SURMOUNT-5 post hoc analysis. Am J Med. 2026 Jul;139(7):913-921. doi: 10.1016/j.amjmed.2026.03.010 US Preventive Services Task Force; Nicholson WK, Silverstein M, Wong JB, et al. Screening for breast cancer: US Preventive Services Task Force recommendation statement. JAMA. 2024;331(22):1918–1930. Trentham-Dietz A, Chapman CH, Jayasekera J, et al. Collaborative modeling to compare different breast cancer screening strategies: a decision analysis for the US Preventive Services Task Force. JAMA. 2024;331(22):1931–1946. Giaquinto AN, Sung H, Miller KD, et al. Breast cancer statistics, 2022. CA Cancer J Clin. 2022;72(6):524–541. Qaseem A, Harrod CS, Balk EM, et al. Screening for breast cancer in asymptomatic, average-risk adult females: a guidance statement from the American College of Physicians (Version 2). Ann Intern Med. 2026.: American Cancer Society. Breast Cancer Facts & Figures 2022–2024. Atlanta, GA: American Cancer Society, 2022. Hu X, Chehal PK, Kaplan C, et al. Racial differences in patient-reported symptoms and adherence to adjuvant endocrine therapy among women with early-stage, hormone receptor-positive breast cancer. JAMA Netw Open. 2022;5(8):e2225485. Torres JM, Sodipo MO, Hopkins MF, Chandler PD, Warner ET. Racial differences in breast cancer survival between Black and White women according to tumor subtype: a systematic review and meta-analysis. J Clin Oncol. 2024;42(35):4225–4234. Bailey ZD, Krieger N, Agénor M, Graves J, Linos N, Bassett MT. Structural racism and health inequities in the USA: evidence and interventions. Lancet. 2017;389(10077):1453–1463. Hypertension. 2026;83:00–00. DOI: 10.1161/HYPERTENSIONAHA.125.25787 Allen RH, Bartz D. Opill: The Over-the-Counter Contraceptive Pill. Obstet Gynecol. 2024;143(2):184-188. doi:10.1097/AOG.0000000000005455 Cahill EP, Kaur S. Advances in contraception research and development. Curr Opin Obstet Gynecol. 2020;32(6):393-398. doi:10.1097/GCO.0000000000000666 Charles DN, Nagarsheth M, Oshman L. Pain Management for IUD Insertion in Primary Care. Am Fam Physician. 2025;111(4):299-301. Chen, C., Strasser, J., Banawa, R., Luo, Q., Bodas, M., Castruccio-Prince, C., Das, K., & Pittman, P. (2022). Who is providing contraception care in the United States? An observational study of the contraception workforce. American journal of obstetrics and gynecology, 226(2), 232.e1–232.e11. https://doi.org/10.1016/j.ajog.2021.08.015 Diedrich,J., Klein, D. Peipert, J.(2017). Long-acting reversible contraception in adolescents: a systematic review and meta-analysis, Am J Ob Gyn, April 2017. http://dx.doi.org/10.1016/j.ajog.2016.12.024 Li RHW, Lo SST, Gemzell-Danielsson K, Fong CHY, Ho PC, Ng EHY. Oral emergency contraception with levonorgestrel plus piroxicam: a randomised double-blind placebo-controlled trial. Lancet. 2023;402(10405):851-858. doi:10.1016/S0140-6736(23)01240-0 Mørch LS, Meaidi A, Corn G, Hargreave M, Wessel Skovlund C. Breast Cancer in Users of Levonorgestrel-Releasing Intrauterine Systems. JAMA. 2024;332(18):1578–1580. doi:10.1001/jama.2024.18575 Nguyen AT, Curtis KM, Tepper NK, et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. MMWR Recomm Rep. 2024;73(4):1-126. Published 2024 Aug 8. doi:10.15585/mmwr.rr7304a1 Paradise SL, Landis CA, Klein DA. Evidence Based Contraception: Common Questions and Answers. American Family Physician. 2022. https://www.aafp.org/afp/2022/0900/contraception The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.
This week, we feature new research on acute myeloid leukemia, achondroplasia, pediatric septic shock, and RAS-mutant lung cancer. We also review the evaluation and management of pulmonary nodules and follow a diagnostic case of recurrent fractures. Perspectives explore reproductive health care, the human–animal bond in health care access, and on creating space for patients' voices in clinical decision making.
Elizabeth Tobin-Tyler is a professor of health services, policy and practice at the Brown University School of Public Health and of family medicine and medical science at Warren Alpert Medical School of Brown University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E. Tobin-Tyler and G. Chalker. Telehealth Access to Mifepristone — Evaluating Reproductive-Coercion Arguments. N Engl J Med 2026;395:833-835.
OSF St. Luke Discusses Mobile Primary Care, Community Outreach, and Hog Days on Wake Up Tri-Counties Samantha Rux talks about OSF OnCall Primary Care on the Go, upcoming community events, and her favorite Hog Days food. Samantha Rux of OSF St. Luke Medical Center recently joined Ken Peele on Wake Up Tri-Counties to discuss a new mobile healthcare initiative from OSF OnCall, community outreach, and the upcoming Hog Days celebration. Rux explained that OSF OnCall, the digital health arm of OSF HealthCare, has been working to transform healthcare access, particularly in rural and underserved communities. Many residents in the area are already familiar with the OSF OnCall King Caravan, a mobile health clinic that serves Henry County and regularly appears at community events. Depending on the available mission partners, the caravan can offer a variety of services, including healthcare navigation and visits with an advanced practice provider. However, Rux said OSF OnCall has recently launched a new concept designed to provide greater consistency in primary care: OSF OnCall Primary Care on the Go. Bringing Primary Care Directly to Communities The new mobile clinic is designed to provide a primary care experience similar to what patients would receive at a traditional brick-and-mortar office—except the clinic can travel to underserved areas. The program is initially launching in the Rockford area, with several permanent stops planned on the city's west side. An advanced practice provider will be available at the mobile clinic, with services including Preventative care Chronic disease management Wellness visits Treatment for common illnesses Lab draws EKGs Other primary care services Rux explained that one of the major differences between Primary Care on the Go and the King Caravan is consistency. While services on the King Caravan can vary depending on the event and mission partners available, Primary Care on the Go is designed around a regular schedule and consistent primary care services. Patients will be able to establish care and schedule appointments, with billing and insurance handled similarly to a traditional primary care office. The mobile service is scheduled to launch August 17th. Those interested in using the service can find clinic locations, schedules, and appointment availability through OSF MyChart and the OSF OnCall website once the service launches. Potential Expansion Rux said the program currently has three permanent stops in the Rockford area, but OSF hopes to expand the service as the program grows. Another potential opportunity is bringing the mobile clinics directly to employers and major manufacturing facilities. Rux noted that people often struggle to find time for routine healthcare appointments between work and responsibilities at home. Having primary care available at or near a workplace could make it easier for employees to receive care without taking significant time away from work. No specific timeline has been announced for expansion into other communities, but Rux said she expects the program could grow quickly if it demonstrates strong results and helps patients who have struggled to access healthcare. OSF St. Luke Preparing for Hog Days The conversation also turned toward Hog Days, one of Kewanee's biggest community celebrations. OSF St. Luke Medical Center is a major sponsor of the Hog Days Stampede, and the OSF OnCall King Caravan will also be present during the festivities. Rux said OSF St. Luke enjoys being involved in Hog Days and getting out into the community to show its support. She also reminded listeners that flu shot season is approaching. Residents can receive flu vaccinations through retail pharmacies or ask about getting a flu shot when making an appointment with their primary care provider.
In this Diving Deep episode, Dr. Robert Pearl and Jeremy Corr examine two very different healthcare debates that share a common problem: when medicine lacks good evidence and aligned incentives, patients and doctors are left with bad choices. The conversation begins with experimental peptides, a fast-growing topic on social media and in wellness circles. Dr. Pearl reviews the FDA's ongoing debate over whether six experimental peptides should be made available to licensed compounding pharmacies. Supporters argue that Americans are already buying these substances through the gray market, often from overseas suppliers, and that regulated access would be safer. Critics argue that expanded access would encourage far more people to use products whose benefits, risks, purity and long-term safety remain uncertain. For Pearl, both sides are partly right, which is why a simple yes or no is the wrong answer. Saying no would not eliminate demand. It would leave many Americans buying peptides online without reliable quality control. Saying yes without conditions would create the impression of FDA approval without the scientific evidence normally required to prove safety and efficacy. Instead, Pearl argues for a third path: pair regulated access with federally coordinated research, safety reporting and controlled studies so patients, doctors and regulators can learn whether these peptides actually work and whether they are safe. The second half of the episode turns to primary care, a specialty Pearl says is in serious trouble. Primary care physicians are overburdened, under-resourced and underpaid compared with specialists. They face growing patient panels, administrative demands, declining autonomy and less interest from medical students entering the field. Pearl acknowledges that primary care leaders are right to ask for more respect, more support and better compensation. But he argues that payers are unlikely to invest substantially more unless primary care can demonstrate better outcomes and lower total costs. That has not happened consistently under traditional fee-for-service or pay-for-performance programs, which reward isolated steps in care rather than overall clinical impact. The solution is capitation. Under this model, primary care doctors would receive a prospective payment to care for a defined population rather than being paid for each visit or service. If chronic diseases are controlled, emergency department use falls and complications decline, both patients and clinicians benefit. But capitation also requires doctors to accept financial risk, organize into larger groups, adopt common clinical standards, coordinate care and empower effective physician leaders. The episode closes with a call for national primary care societies to lead. Pearl says they can help doctors form groups, negotiate capitated contracts, purchase stop-loss protection, implement generative AI, build clinical infrastructure and spread best practices from early demonstration programs. Across both topics, Pearl returns to the same point. Whether the issue is experimental peptides or the future of primary care, patients need evidence, doctors need accountability and the system needs incentives that reward better health. For more, tune into this month's episode and check out the link below. Helpful links: The Best FDA Decision On Peptide Authorization Isn't Yes Or No (Forbes) Monthly Musings on American Healthcare (RobertPearlMD.com) * * * Dr. Robert Pearl is the author of ChatGPT, MD: How AI-Empowered Patients & Doctors Can Take Back Control of American Medicine. Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple, Spotify or wherever you find podcasts. Join the conversation or suggest a guest by following the show on X and LinkedIn. The post FHC #226: Peptides, primary care & the false choices in American medicine appeared first on Fixing Healthcare.
Intro (0:35),Acute Otitis Externa (1:52),Acute Otitis Media (3:24),Acute Sinusitis (5:41),Strep Throat (7:05),Acute Bronchitis (8:14),Community-Acquired Pneumonia (8:57),Pertussis (11:15),Impetigo (12:04),Cellulitis (13:01),Abscess (14:05),Bite Wounds (14:59),Lyme Disease (15:54),Asymptomatic Bacteriuria (17:19),Cystitis (18:18),Pyelonephritis (20:02),Prostatitis (21:22),Heliobacter pylori (22:02),Clostridioides difficile (23:22),Rapid Fire Antibiotic Prescribing Pearls (24:50),Practice Questions (26:55)
Credits: 0.75 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-500 Overview: To celebrate our 500th episode, each member of our team revisits a popular topic from the podcast's earlier installments—GLP-1s, cervical and breast cancer screening, diet and exercise, contraception, hypertension, and lipid management—to trace how the evidence and guidelines have changed since it was first covered. Whether you're catching up or reinforcing what you know, this milestone episode helps you bring the latest evidence into everyday patient care. Guest: Robert Baldor, MD, Alan Ehrlich, MD, Susan Feeney, DNP, FNP-BC; FAANP, Jillian Joseph, PA, Mariyan L. Montaque, DNP, FNP-BC, Jill Terrien PhD, ANP-BC, FAAN Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com Episode resource links: Zhou H et al. Evaluation and Comparison of the PREVENT and Pooled Cohort Equations for 10‐Year Atherosclerotic Cardiovascular Risk Prediction. Journal of the American Heart Association Volume 14, Number 4 Goff DC et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation. 2014;129:S49–S73. Circulation. 2018 Jul 24;138(4):345-355. eClinicalMedicine 2025: 103741. Curry, J. (2018). Screening for cervical cancer: US Preventive Services Task Force Recommendation Statement. JAMA.320(7):674-686. doi:10.1001/jama.2018.10897 https://www.ncbi.nlm.nih.gov/pubmed/30140884 Perkins RB, Wolf AMD, Church TR, et al. Self-collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline. CA Cancer J Clin. 2026;e70041. doi:10.3322/caac.70041 Screening for Cervical Cancer (2026). Obstetrics & Gynecology, 148(1), e63-e67. https://doi.org/10.1097/AOG.0000000000006257 Jad Zeitouni, Nosayaba Osazuwa-Peters, Yusuf Dundar, Gregory Zimet, Mark A. Varvares. (2025). Two decades of the HPV vaccine: its promise, progress, prospects, projections, and posterity, The Lancet Regional Health - Americas, (51), https://doi.org/10.1016/j.lana.2025.101243 Diabetes, Obesity and Metabolism 28, no. 6 (2026): 5043–5057, https://doi.org/10.1111/dom.70698. Relationship of early rapid weight loss to efficacy and safety of tirzepatide and semaglutide for obesity: SURMOUNT-5 post hoc analysis. Am J Med. 2026 Jul;139(7):913-921. doi: 10.1016/j.amjmed.2026.03.010 US Preventive Services Task Force; Nicholson WK, Silverstein M, Wong JB, et al. Screening for breast cancer: US Preventive Services Task Force recommendation statement. JAMA. 2024;331(22):1918–1930. Trentham-Dietz A, Chapman CH, Jayasekera J, et al. Collaborative modeling to compare different breast cancer screening strategies: a decision analysis for the US Preventive Services Task Force. JAMA. 2024;331(22):1931–1946. Giaquinto AN, Sung H, Miller KD, et al. Breast cancer statistics, 2022. CA Cancer J Clin. 2022;72(6):524–541. Qaseem A, Harrod CS, Balk EM, et al. Screening for breast cancer in asymptomatic, average-risk adult females: a guidance statement from the American College of Physicians (Version 2). Ann Intern Med. 2026.: American Cancer Society. Breast Cancer Facts & Figures 2022–2024. Atlanta, GA: American Cancer Society, 2022. Hu X, Chehal PK, Kaplan C, et al. Racial differences in patient-reported symptoms and adherence to adjuvant endocrine therapy among women with early-stage, hormone receptor-positive breast cancer. JAMA Netw Open. 2022;5(8):e2225485. Torres JM, Sodipo MO, Hopkins MF, Chandler PD, Warner ET. Racial differences in breast cancer survival between Black and White women according to tumor subtype: a systematic review and meta-analysis. J Clin Oncol. 2024;42(35):4225–4234. Bailey ZD, Krieger N, Agénor M, Graves J, Linos N, Bassett MT. Structural racism and health inequities in the USA: evidence and interventions. Lancet. 2017;389(10077):1453–1463. Hypertension. 2026;83:00–00. DOI: 10.1161/HYPERTENSIONAHA.125.25787 Allen RH, Bartz D. Opill: The Over-the-Counter Contraceptive Pill. Obstet Gynecol. 2024;143(2):184-188. doi:10.1097/AOG.0000000000005455 Cahill EP, Kaur S. Advances in contraception research and development. Curr Opin Obstet Gynecol. 2020;32(6):393-398. doi:10.1097/GCO.0000000000000666 Charles DN, Nagarsheth M, Oshman L. Pain Management for IUD Insertion in Primary Care. Am Fam Physician. 2025;111(4):299-301. Chen, C., Strasser, J., Banawa, R., Luo, Q., Bodas, M., Castruccio-Prince, C., Das, K., & Pittman, P. (2022). Who is providing contraception care in the United States? An observational study of the contraception workforce. American journal of obstetrics and gynecology, 226(2), 232.e1–232.e11. https://doi.org/10.1016/j.ajog.2021.08.015 Diedrich,J., Klein, D. Peipert, J.(2017). Long-acting reversible contraception in adolescents: a systematic review and meta-analysis, Am J Ob Gyn, April 2017. http://dx.doi.org/10.1016/j.ajog.2016.12.024 Li RHW, Lo SST, Gemzell-Danielsson K, Fong CHY, Ho PC, Ng EHY. Oral emergency contraception with levonorgestrel plus piroxicam: a randomised double-blind placebo-controlled trial. Lancet. 2023;402(10405):851-858. doi:10.1016/S0140-6736(23)01240-0 Mørch LS, Meaidi A, Corn G, Hargreave M, Wessel Skovlund C. Breast Cancer in Users of Levonorgestrel-Releasing Intrauterine Systems. JAMA. 2024;332(18):1578–1580. doi:10.1001/jama.2024.18575 Nguyen AT, Curtis KM, Tepper NK, et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. MMWR Recomm Rep. 2024;73(4):1-126. Published 2024 Aug 8. doi:10.15585/mmwr.rr7304a1 Paradise SL, Landis CA, Klein DA. Evidence Based Contraception: Common Questions and Answers. American Family Physician. 2022. https://www.aafp.org/afp/2022/0900/contraception The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.
SPONSORED BY NURP Nurp is algorithmic trading designed specifically for busy professionals who don't have time to watch markets. Check out start.nurp.com/doctors to learn more. --- What happens when the healthcare system built to treat illness leaves patients feeling unsupported, overwhelmed, and responsible for coordinating their own care? At just 23 years old, Chloe Harrouche was diagnosed with breast cancer. Although she had specialists guiding each part of her treatment, no one was managing the complete picture. After treatment, she encountered another major gap: little meaningful guidance on prevention, nutrition, fertility, or long-term wellness. That experience inspired Chloe to co-found The Lanby, a modern concierge medical practice designed to make primary care more proactive, coordinated, and patient-centered. In this conversation, Chloe joins May and Tim to discuss how her experience as a patient shaped her vision for a different kind of healthcare. They explore the shortcomings of traditional fee-for-service medicine, the value of coordinated care, and why prevention and wellness should be central to primary care—not an afterthought. In This Episode Chloe's breast cancer diagnosis at age 23 Navigating treatment without anyone coordinating the full picture Why traditional medicine often prioritizes treatment over prevention The lack of support patients receive after surviving a serious illness Chloe's difficult fertility journey and path to motherhood Why women frequently place their own health last The problems created by rushed, fragmented medical care How membership-based medicine can better align patients and providers The role of nutrition, wellness, and care coordination in primary care How The Lanby is working to create a more supportive patient experience About Chloe Harrouche Chloe Harrouche is the co-founder and CEO of The Lanby, a modern concierge medical practice in New York City that combines primary care, functional medicine, wellness, and care coordination. Her experience as a young breast cancer survivor gave her firsthand insight into the gaps patients face when navigating complex medical care. Drawing on her background in bioengineering, healthcare strategy, and technology consulting, Chloe helped build The Lanby around a proactive, relationship-based approach to health. Connect with Chloe and The Lanby Learn more about Chloe HarroucheVisit The LanbyConnect with Chloe on LinkedInListen to The Lanby's Get Well, Better podcast Connect with BS Free MD BS Free MD WebsiteInstagram If you enjoyed this episode, follow the podcast and share it with someone ready for a more proactive, patient-centered approach to healthcare. This podcast is for entertainment and informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional regarding your individual medical needs. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Rural Health News is a weekly segment of Rural Health Today, a podcast by Hillsdale Hospital. News sources for this episode: Twilight Greenaway Et al., “Hurricane Lala Passes Big Island: Hawaiʻi Spared From Direct Hit,” August 15, 2026, https://www.civilbeat.org/2026/08/hurricane-lala-brings-rain-and-strong-winds-thousands-on-hawaii-island-lose-power/, Honolulu Civil Beat. Joseph S. Pete, “2 Methodist Hospitals campuses have power again, offering public food and services,” August 18, 2026, https://nwitimes.com/news/local/lake/article_58a16c9f-b147-427c-bed9-9007ad31f581.html?utm_campaign=snd-autopilot&utm_medium=social&utm_source=facebook_The_Times_of_Northwest_Indiana&fbclid=IwY2xjawT9erNwZG9mAWV4dG4DYWVtAjEwAHNydGMGYXBwX2lkEDIyMjAzOTE3ODgyMDA4OTIAAR4BcplBpGKi72APyCMIiTHemUnNCkZM9vFSlXN-Wzg6GYqmTX86J6DqJ35WCA_aem_knYqaiBHKDJx0OGlMzTrlQ, NWI Times. Aaron Dorman, “Power Down,” August 26, 2026, https://chicagohealthonline.com/northwest-indiana-storms-power-outage-health/, Chicago Health. The Associated Press, “'Survival mode': Indiana residents endure a ninth day without power,” August 21, 2026, https://www.wunc.org/2026-08-21/survival-mode-indiana-residents-endure-a-ninth-day-without-power, WUNC News. Kristiane Huber, “How States Are Navigating the Intersection of Disasters and Public Health,” May 5, 2026, https://www.pew.org/en/research-and-analysis/articles/2026/05/05/how-states-are-navigating-the-intersection-of-disasters-and-public-health, The Pew Charitable Trust. American Hospital Association, “Fact Sheet: Facility Fees,” February 2025, https://www.aha.org/fact-sheets/2025-02-20-fact-sheet-facility-fees. Stephen Abresch, “Michigan Introduces Facility Fee Restriction Legislation,” April 10, 2026, https://archive.ascfocus.org/content2/articles-content/articles/2026/digital-debut/michigan-introduces-facility-fee-restriction-legislation, ASC Focus. Jayme Lozano Carver, “Lack of broadband service, funding gives rise to telehealth services in rural clinics,” August 6, 2026, https://www.texastribune.org/2026/08/06/rural-texas-telehealth-services-broadband-access/, The Texas Tribune. Rural Health Today is a production of Hillsdale Hospital in Hillsdale, Michigan and a member of the Health Podcast Network. Our host is JJ Hodshire, our producer is Kyrsten Newlon, and our audio engineer is Kenji Ulmer. Special thanks to our special guests for sharing their expertise on the show, and also to the Hillsdale Hospital marketing team. If you want to submit a question for us to answer on the podcast or learn more about Rural Health Today, visit ruralhealthtoday.com.
Credits: 0.75 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-500 Overview: To celebrate our 500th episode, each member of our team revisits a popular topic from the podcast's earlier installments—GLP-1s, cervical and breast cancer screening, diet and exercise, contraception, hypertension, and lipid management—to trace how the evidence and guidelines have changed since it was first covered. Whether you're catching up or reinforcing what you know, this milestone episode helps you bring the latest evidence into everyday patient care. Guest: Robert Baldor, MD, Alan Ehrlich, MD, Susan Feeney, DNP, FNP-BC; FAANP, Jillian Joseph, PA, Mariyan L. Montaque, DNP, FNP-BC, Jill Terrien PhD, ANP-BC, FAAN Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com Episode resource links: Zhou H et al. Evaluation and Comparison of the PREVENT and Pooled Cohort Equations for 10‐Year Atherosclerotic Cardiovascular Risk Prediction. Journal of the American Heart Association Volume 14, Number 4 Goff DC et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation. 2014;129:S49–S73. Circulation. 2018 Jul 24;138(4):345-355. eClinicalMedicine 2025: 103741. Curry, J. (2018). Screening for cervical cancer: US Preventive Services Task Force Recommendation Statement. JAMA.320(7):674-686. doi:10.1001/jama.2018.10897 https://www.ncbi.nlm.nih.gov/pubmed/30140884 Perkins RB, Wolf AMD, Church TR, et al. Self-collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline. CA Cancer J Clin. 2026;e70041. doi:10.3322/caac.70041 Screening for Cervical Cancer (2026). Obstetrics & Gynecology, 148(1), e63-e67. https://doi.org/10.1097/AOG.0000000000006257 Jad Zeitouni, Nosayaba Osazuwa-Peters, Yusuf Dundar, Gregory Zimet, Mark A. Varvares. (2025). Two decades of the HPV vaccine: its promise, progress, prospects, projections, and posterity, The Lancet Regional Health - Americas, (51), https://doi.org/10.1016/j.lana.2025.101243 Diabetes, Obesity and Metabolism 28, no. 6 (2026): 5043–5057, https://doi.org/10.1111/dom.70698. Relationship of early rapid weight loss to efficacy and safety of tirzepatide and semaglutide for obesity: SURMOUNT-5 post hoc analysis. Am J Med. 2026 Jul;139(7):913-921. doi: 10.1016/j.amjmed.2026.03.010 US Preventive Services Task Force; Nicholson WK, Silverstein M, Wong JB, et al. Screening for breast cancer: US Preventive Services Task Force recommendation statement. JAMA. 2024;331(22):1918–1930. Trentham-Dietz A, Chapman CH, Jayasekera J, et al. Collaborative modeling to compare different breast cancer screening strategies: a decision analysis for the US Preventive Services Task Force. JAMA. 2024;331(22):1931–1946. Giaquinto AN, Sung H, Miller KD, et al. Breast cancer statistics, 2022. CA Cancer J Clin. 2022;72(6):524–541. Qaseem A, Harrod CS, Balk EM, et al. Screening for breast cancer in asymptomatic, average-risk adult females: a guidance statement from the American College of Physicians (Version 2). Ann Intern Med. 2026.: American Cancer Society. Breast Cancer Facts & Figures 2022–2024. Atlanta, GA: American Cancer Society, 2022. Hu X, Chehal PK, Kaplan C, et al. Racial differences in patient-reported symptoms and adherence to adjuvant endocrine therapy among women with early-stage, hormone receptor-positive breast cancer. JAMA Netw Open. 2022;5(8):e2225485. Torres JM, Sodipo MO, Hopkins MF, Chandler PD, Warner ET. Racial differences in breast cancer survival between Black and White women according to tumor subtype: a systematic review and meta-analysis. J Clin Oncol. 2024;42(35):4225–4234. Bailey ZD, Krieger N, Agénor M, Graves J, Linos N, Bassett MT. Structural racism and health inequities in the USA: evidence and interventions. Lancet. 2017;389(10077):1453–1463. Hypertension. 2026;83:00–00. DOI: 10.1161/HYPERTENSIONAHA.125.25787 Allen RH, Bartz D. Opill: The Over-the-Counter Contraceptive Pill. Obstet Gynecol. 2024;143(2):184-188. doi:10.1097/AOG.0000000000005455 Cahill EP, Kaur S. Advances in contraception research and development. Curr Opin Obstet Gynecol. 2020;32(6):393-398. doi:10.1097/GCO.0000000000000666 Charles DN, Nagarsheth M, Oshman L. Pain Management for IUD Insertion in Primary Care. Am Fam Physician. 2025;111(4):299-301. Chen, C., Strasser, J., Banawa, R., Luo, Q., Bodas, M., Castruccio-Prince, C., Das, K., & Pittman, P. (2022). Who is providing contraception care in the United States? An observational study of the contraception workforce. American journal of obstetrics and gynecology, 226(2), 232.e1–232.e11. https://doi.org/10.1016/j.ajog.2021.08.015 Diedrich,J., Klein, D. Peipert, J.(2017). Long-acting reversible contraception in adolescents: a systematic review and meta-analysis, Am J Ob Gyn, April 2017. http://dx.doi.org/10.1016/j.ajog.2016.12.024 Li RHW, Lo SST, Gemzell-Danielsson K, Fong CHY, Ho PC, Ng EHY. Oral emergency contraception with levonorgestrel plus piroxicam: a randomised double-blind placebo-controlled trial. Lancet. 2023;402(10405):851-858. doi:10.1016/S0140-6736(23)01240-0 Mørch LS, Meaidi A, Corn G, Hargreave M, Wessel Skovlund C. Breast Cancer in Users of Levonorgestrel-Releasing Intrauterine Systems. JAMA. 2024;332(18):1578–1580. doi:10.1001/jama.2024.18575 Nguyen AT, Curtis KM, Tepper NK, et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. MMWR Recomm Rep. 2024;73(4):1-126. Published 2024 Aug 8. doi:10.15585/mmwr.rr7304a1 Paradise SL, Landis CA, Klein DA. Evidence Based Contraception: Common Questions and Answers. American Family Physician. 2022. https://www.aafp.org/afp/2022/0900/contraception The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.
What questions do you have about GLP-1 medications and weight loss? In this episode of Back on Track: Achieving Healthy Weight Loss, I'm doing something a little different. I'm answering five real questions that viewers have left on my YouTube videos and social media about weight loss medications. I'll talk about whether you can take Contrave with a GLP-1, whether GLP-1 medications are an option if you have hypothyroidism or Hashimoto's disease, and whether it's safe to increase your dose faster if you aren't experiencing side effects. I'll also explain what to do if you need to change your injection day or miss a dose, and how to think about calorie intake when you're trying to lose weight. These are questions I hear frequently, and I want to give you a better understanding of the issues to discuss with your own healthcare provider. This podcast is for education only, and because I don't know your individual medical history, it's important to talk with your own doctor about what's right for you. Episode Highlights: Can Contrave can be taken with a GLP-1 How Contrave may help with hunger, cravings, and food noise GLP-1 medications and hypothyroidism or Hashimoto's disease Which thyroid conditions are contraindications for GLP-1 medications Why I recommend starting at a low dose and increasing slowly How I decide when it may be time for a patient to increase their dose What to do if you need to change your GLP-1 injection day What happens if you miss a GLP-1 dose Why eating too little can work against your weight-loss efforts How the NIH Body Weight Planner can help you determine your calorie needs Why fueling your body with balanced meals is important during weight loss And this is just Part 1. In Part 2 of Ask the Obesity Doctor, I'll answer more questions about GLP-1 safety, compounded and counterfeit medications, black-market peptides, medication interactions, side effects, and "Ozempic face." If you're using a GLP-1 medication, considering one, or simply have questions about weight loss medications, I hope these answers help you have a more informed conversation with your healthcare provider. Connect with Dr. Alicia Shelly Website | drshellymd.com Facebook | www.facebook.com/drshellymd Instagram | @drshellymd Linked In | www.linkedin.com/in/drshellymd Twitter | @drshellymd About Dr. Alicia Shelly Dr. Alicia Shelly was raised in Atlanta, GA. She received her Doctorate of Medicine from Case Western Reserve University School of Medicine in Cleveland, OH. Dr. Shelly has been practicing Primary Care and Obesity medicine since 2014. In 2017, she became a Diplomat of the American Board of Obesity Medicine. She is the lead physician at the Wellstar Medical Center Douglasville. She started a weekly podcast & Youtube channel entitled Back on Track: Achieving Healthy Weight loss, where she discusses how to get on track and stay on track with your weight loss journey. She has spoken for numerous local and national organizations, including the Obesity Medicine Association, and the Georgia Chapter of the American Society of Metabolic and Bariatric Surgeons. She has been featured on CNN, Fox 5 News, Bruce St. James Radio show, Upscale magazine, and Shape.com. She was named an honoree of the 2021 Atlanta Business Chronicle's 40 under 40 award. She also is a collaborating author for the, "Made for More: Physician Entrepreneurs who Live Life and Practice Medicine on their own terms''. Resources: FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!)
For educational purposes only It's time to get superior results with us! Support your health & wellness journey with #Titan! Feel Better, Look Better & Perform Better with TitanMedical Center! HormoneOptimization #Health #Wellness #TitanMedicalCenter
Vaccine-preventable diseases have resurged despite decades of successful mitigation, due in part to changing vaccine recommendations. Featuring audio from a live webinar with experts Paul G. Auwaerter, MD, MBA, FIDSA, FACP, and Camille Nelson Kotton, MD, FIDSA, FAST, this podcast explores current events in vaccines and their implications on patient vaccine uncertainty, with expert discussion of learner-submitted questions. For more, and to download the accompanying slides, visit our program page. Topics covered include: Current Outbreaks of Vaccine-Preventable Diseases Changes in Current Federal HHS/CDC Vaccine Recommendations Resources to Consult for Vaccine Recommendations The Vaccine Hesitancy Continuum Shared Clinical Decision-making Memorable Messaging Tools Presenters: Paul G. Auwaerter, MD, MBA Sherrilyn and Ken Fisher Professor of Medicine Divisions of Infectious Diseases and General Internal Medicine Johns Hopkins University School of Medicine Baltimore, Maryland Camille Nelson Kotton, MD, FIDSA, FAST Clinical Director, Transplant and Immunocompromised Host Infectious Diseases Infectious Diseases Division Massachusetts General Hospital Associate Professor, Harvard Medical School Boston, Massachusetts Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
"I'd already finished my cardiovascular unit. I'd finished my pulmonary unit. I had never heard about this in any of my classes." That was Dr. Joel Bervell's reaction to discovering that a device used every day in hospitals -- the pulse oximeter -- reads less accurately on darker skin tones. He posted a 30-second video about this consequential discrepancy that, to his utter surprise, gained over 500,000 views by the next morning. That video launched Dr. Bervell into orbit as a social media presence and created his identity as The Medical Mythbuster. In just a few years, he's built a following of two million people, earned a Peabody Award and was named to the inaugural Time 100 Creators list, all while finishing his residency. On this episode of Raise the Line, host Lindsey Smith welcomes Dr. Bervell to explore the roots of this kind of bias and the real world impact of drawing attention to it. “The most impactful biases in medicine exist because no one stops to ask who was included in the original data and who was left out,” Dr. Bervell explains. Stay tuned to also learn about: His YouTube animated series The Doctor is In which helps kids understand how their bodies work, as well as providing medical role models; How to build trust with marginalized communities; His forthcoming book, The Default Body which examines who medicine was actually designed for. Mentioned in this episode:Dr. Bervell on InstagramTikTok ChannelFacebook"The Doctor Is In" Show If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast
This week on Faisel and Friends, we are discussing What Clinicians Need to Know This Fall: Vaccines, Communication, and Trust. Faisel and Dan are talking with Dr. Gretchen LaSalle, former AAFP vaccine science fellow.Our conversation explores strategies for discussing vaccines in the clinic, the reality that immunization is one of the most powerful preventative health tools we have, and an approach for building bridges with patients through improving science communication.
For educational purposes only It's time to get superior results with us! Support your health & wellness journey with #Titan! Feel Better, Look Better & Perform Better with TitanMedical Center! HormoneOptimization #Health #Wellness #TitanMedicalCenter
In this episode, Neil Machhar, Chief Executive Officer, Greenbrook Medical, discusses Greenbrook's high-touch primary care model for seniors, its growing partnership with Tampa General Hospital, and plans for expansion. He also shares insights on Medicare Advantage headwinds, sustainable growth, and building a team-first culture.
About 30% to 40% of the world's population is affected by some form of allergic disease, making allergy a routine consideration in primary care. But as interest in the microbiome grows, clinicians and patients face an important question: what does the evidence actually tell us about its role in allergic disease? This episode explores immune development, the hygiene and biodiversity hypotheses, food allergy, early-life tolerance, the gut-skin axis, atopic dermatitis, asthma, allergic rhinitis, antibiotic exposure, diagnostic testing, and early peanut introduction. The discussion separates established evidence from emerging associations and considers what, if anything, should change in clinical practice today. Clinicians will come away with practical guidance on maintaining evidence-based allergy diagnosis and management while understanding where microbiome research may shape future approaches to prevention and care. Resources and references: https://www.thermofisher.com/phadia/us/en/resources/immunocast/microbiome-and-allergy-what-primary-care-should-know.html?cid=0ct_3pc_05032024_9SGOV4
One month into the Medicare GLP-1 Bridge program, I've learned that getting approved is less complicated once you understand the pathway. But there are several important details that can cause delays if you don't know what to look for. In this episode, I walk you through what I've learned from helping patients navigate the Medicare GLP-1 Bridge during its first month. We cover who qualifies, which medications and formulations are included, when you may need to use Medicare Part D instead, and what your doctor, pharmacy, and you need to do to keep the process moving. I'll also explain why your current BMI may not be the BMI that matters, why the pharmacy claim needs to happen before the prior authorization, and why staying engaged with both your pharmacy and doctor's office can make a difference. And once you actually get your medication, I shift the conversation to what you should be doing to maximize your results, including getting adequate protein, moving your body, strength training, and staying engaged with your medical team. If you're trying to navigate the Medicare GLP-1 Bridge program for yourself or a loved one, this episode will help you understand the process and the questions you need to ask. Episode Highlights: ● What the Medicare GLP-1 Bridge program is and how it differs from Medicare Part D ● The three main eligibility pathways for the Bridge program ● Why your BMI when you started GLP-1 therapy may matter more than your current BMI ● When certain medical conditions may require you to use the regular Medicare Part D pathway ● Why having eligible Medicare Part D coverage matters ● Which GLP-1 medications and formulations are included in the Bridge program ● Why the correct Zepbound formulation matters ● What your pharmacy needs from your Medicare information ● Why the pharmacy claim needs to happen before the prior authorization ● How to follow up when your prescription seems stuck in the process ● What to focus on once you actually receive your medication ● Why protein, exercise, strength training, and medical follow-up remain important ● What we currently know about what happens when the Bridge program ends Connect with Dr. Alicia Shelly Website | drshellymd.com Facebook | www.facebook.com/drshellymd Instagram | @drshellymd Linked In | www.linkedin.com/in/drshellymd Twitter | @drshellymd About Dr. Alicia Shelly Dr. Alicia Shelly was raised in Atlanta, GA. She received her Doctorate of Medicine from Case Western Reserve University School of Medicine in Cleveland, OH. Dr. Shelly has been practicing Primary Care and Obesity medicine since 2014. In 2017, she became a Diplomat of the American Board of Obesity Medicine. She is the lead physician at the Wellstar Medical Center Douglasville. She started a weekly podcast & Youtube channel entitled Back on Track: Achieving Healthy Weight loss, where she discusses how to get on track and stay on track with your weight loss journey. She has spoken for numerous local and national organizations, including the Obesity Medicine Association, and the Georgia Chapter of the American Society of Metabolic and Bariatric Surgeons. She has been featured on CNN, Fox 5 News, Bruce St. James Radio show, Upscale magazine, and Shape.com. She was named an honoree of the 2021 Atlanta Business Chronicle's 40 under 40 award. She also is a collaborating author for the, "Made for More: Physician Entrepreneurs who Live Life and Practice Medicine on their own terms''. Resources: FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!)
Photo by National Cancer Institute on Unsplash In 2015, the Primary Care Development Corporation conducted an analysis of primary care capacity in counties in New York State. Delaware County in the Catskill region of the state was found to be a primary care desert. Since that time, Margaretville Hospital, a critical access hospital that is part of Health Alliance of the Hudson Valley and WMCHealth, has worked to build primary care in the region. Among the new providers at the hospital's primary care practice is family nurse practitioner, Erin Black, MSN, FNP. HealthCetera producer and host Diana Mason, RN, talked with Erin about her work in primary care and health care in general. This interview first aired on July 22, 2026, on HealthCetera in the Catskills on WIOX Radio. The post Primary Care in the Catskills appeared first on HealthCetera.
Beyond The Prescription: Insider Tips On How To Be A Better Patient Despite incredible medical breakthroughs and massive funding, America continues to lag behind similar nations in overall health outcomes. The root of this crisis lies in our fragmented medical system, where profit is valued over true health. Our expert gives step-by-step advice on how to get exactly what you need out of your healthcare experience. Guest: Dr. Lucy McBride, primary care physician, Ackerly McBride Group, author, Beyond the Prescription Host and Producer: Kristen Farrah The Disease Of Kings: Breaking The Stigma Around Gout While an active lifestyle can prevent a lot of illnesses, some debilitating conditions strike out of nowhere. Gout is a type of inflammatory arthritis affecting over twelve million Americans. The pain can be so severe that even the weight of a bedsheet is unbearable. Our experts explain the root cause of gout and why a persistent, outdated stigma keeps millions of sufferers from seeking help. Guests: Dr. Suneet Grewal, rheumatologist, East Bay Rheumatology Medical Group; Glenn, patient Host: Greg Johnson Producer: Kristen Farrah Facebook: ingoodhealthpodX: @ ingoodhealthpodIG: @ingoodhealthpodYouTube: @ingoodhealthpodSpotify Apple Podcast In Good Health PodcastSubscribed to the newsletterFull ArchiveContact UsBecome an Affiliate Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Beyond The Prescription: Insider Tips On How To Be A Better Patient Despite incredible medical breakthroughs and massive funding, America continues to lag behind similar nations in overall health outcomes. The root of this crisis lies in our fragmented medical system, where profit is valued over true health. Our expert gives step-by-step advice on how to get exactly what you need out of your healthcare experience. Guest: Dr. Lucy McBride, primary care physician, Ackerly McBride Group, author, Beyond the Prescription Host and Producer: Kristen Farrah Facebook: ingoodhealthpodX: @ ingoodhealthpodIG: @ingoodhealthpodYouTube: @ingoodhealthpodSpotify Apple Podcast In Good Health PodcastSubscribed to the newsletterFull ArchiveContact UsBecome an Affiliate Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Are vaccines safe? How should patients interpret reports of vaccine injuries and adverse effects? Is natural immunity better than vaccine-induced immunity? And why did trust in vaccines and public health decline so dramatically during the COVID-19 pandemic? In this episode of Confessions of a Male Gynecologist, Dr. Shawn Tassone sits down with Harvard-trained physician and author, Dr. Michael T. Myers, Jr., MD, MBA, for an in-depth discussion about vaccines, vaccine safety, medical misinformation, public health, and the growing distrust surrounding vaccination. Dr. Myers explains how vaccines are evaluated for safety and effectiveness, why correlation does not necessarily prove that a vaccine caused a reported health problem, and how systems such as the Vaccine Adverse Event Reporting System (VAERS) are actually intended to be used. They also discuss the reality of vaccine injuries, why adverse events deserve careful investigation, and why self-reported vaccine reactions must be interpreted within the larger scientific and clinical context. The conversation examines how communication during the COVID-19 pandemic affected vaccine confidence and contributed to increased vaccine hesitancy. Dr. Tassone and Dr. Myers discuss what public health officials and physicians could have communicated differently, the tension between vaccine mandates and individual autonomy, and why rebuilding trust between patients and healthcare professionals is essential. They also explore the childhood vaccination schedule, herd immunity, natural immunity versus vaccine-induced immunity, and the resurgence of vaccine-preventable diseases such as measles. Dr. Myers explains why the timing of childhood vaccines matters, how widespread vaccination protects both individuals and communities, and what can happen when vaccination rates fall. Rather than dismissing questions about vaccines, this conversation emphasizes the importance of informed discussion, transparent communication, scientific evidence, and allowing patients to ask difficult questions without immediately labeling them as anti-vaccine. For anyone trying to understand vaccine safety, vaccine adverse effects, VAERS, childhood vaccines, vaccine mandates, natural immunity, measles outbreaks, or the lasting impact of COVID-19 on trust in medicine, this episode provides a physician-led discussion of one of the most divisive public health topics of the last several years. In this episode, you will learn: How vaccines have played a major role in reducing serious illness, disability, and death from infectious diseases. Why vaccine misinformation and distrust increased substantially during and after the COVID-19 pandemic. How communication from physicians and public health leaders can have a significant impact on vaccine confidence and patient trust. Why vaccine safety concerns should be taken seriously, but a medical event occurring after vaccination does not automatically mean the vaccine caused that event. VAERS is an important surveillance system designed to identify potential safety signals, but reports submitted to VAERS do not by themselves establish causation. Vaccine injuries and adverse reactions can occur, and those cases deserve careful evaluation within the context of the overall risks and benefits of vaccination. How the childhood vaccination schedule is designed around disease risk, immune response, vaccine effectiveness, and the ages when children are most vulnerable to specific infections. Reasons natural immunity is not automatically safer, stronger, or preferable to vaccine-induced immunity because acquiring natural immunity generally requires experiencing the infection itself. Examples of how vaccinations have dramatically reduced diseases such as measles, but declining vaccination rates can allow previously controlled diseases to return. How herd immunity helps protect individuals who cannot receive certain vaccines or who may not develop a strong immune response. Breaking down vaccine mandates that raise difficult questions involving public health, personal autonomy, individual rights, and responsibility to the broader community. How physicians can address vaccine hesitancy more effectively by listening to patients' concerns rather than immediately dismissing or criticizing them. Why trust between patients and healthcare professionals is essential when discussing vaccination and other controversial medical topics. Reasons clear communication about both the benefits and potential risks of vaccination is critical for informed medical decision-making. Why continued vaccine surveillance and research are necessary because scientific understanding evolves as additional data becomes available. Questions Dr. Mike Myers Answered in This Episode: Are vaccines safe? Dr. Myers discusses how vaccine safety is evaluated, how adverse events are monitored, and why risk must be considered alongside the risks associated with the diseases vaccines are designed to prevent. What does a VAERS report actually mean? VAERS allows healthcare professionals, vaccine manufacturers, patients, and others to report health events occurring after vaccination. These reports can help identify potential safety signals, but a VAERS report alone does not prove that a vaccine caused the reported event. Are vaccine injuries real? Yes. Adverse reactions can occur following vaccination. The challenge is determining whether a specific medical event was actually caused by the vaccine or simply occurred within the same time period. Is natural immunity better than vaccine immunity? Natural infection can produce immunity, but obtaining that immunity requires becoming infected and accepting the potential complications of the disease. Vaccine-induced immunity attempts to create immune protection without requiring someone to experience the full disease. Why do children receive vaccines according to a specific schedule? The childhood vaccination schedule is designed around when children are most vulnerable to certain diseases and when vaccines can provide effective protection. Why is measles returning in some communities? Measles is extremely contagious. When vaccination rates fall below levels needed to maintain community protection, outbreaks become more likely. Did COVID-19 change how people view vaccines? The pandemic significantly altered public trust in healthcare institutions, government agencies, physicians, and vaccines. Dr. Tassone and Dr. Myers discuss how inconsistent messaging and rapidly evolving recommendations contributed to that distrust. Should vaccines be mandated? Vaccine mandates involve a difficult balance between individual autonomy and protecting community health, making them one of the more complicated ethical questions surrounding vaccination policy. About Dr. Mike Myers Dr. Michael T. Myers, Jr., MD, MBA was the Chief of Primary Care, Pediatrics, and Practice Transformation for Summit Health New Jersey, one of the state's largest medical groups, before he retired in 2025. A physician leader with more than 35 years of experience in medical group practice management, public health initiatives, and health care consulting, Dr. Myers has held leadership positions at Partners HealthCare in Boston (now Mass General Brigham), Blue Cross Blue Shield of Massachusetts, and PricewaterhouseCoopers. During the COVID-19 pandemic, he served as COVID-19 scientific consultant to Stonehill College in Easton, Massachusetts, and was appointed Adjunct Lecturer. His first book, COVID-ology: A Field Guide [CRC Press | 2022], an academic title for college health and science majors, was released in December 2022. Dr. Myers completed his primary care residency at Mount Auburn Hospital in Cambridge, Massachusetts, and received his MD from Harvard, BA from Johns Hopkins, and MBA from Northeastern University. Connect with Dr. Mike Myers Visit Dr. Myers Website | Dr.MikeMyers.com Purchase Dr. Mike Myers Latest Book, The Vaccine Bible, on Amazon Purchase Dr. Mike Myers Latest Book, The Vaccine Bible, on Bookshop.org Purchase Dr. Mike Myers Latest Book, The Vaccine Bible, on Audiobook Episode Resources: Work with Dr. Tassone | Tassone Advanced Gynecology Please contact the clinic directly at (512) 956- 0296 with all scheduling inquiries. Purchase Dr. Tassone's Best-Selling Book | The Hormone Balance Bible Dr. Tassone's Integrative Hormonal Archetype Quiz | Discover Your Hormonal Archetype Medical Disclaimer This podcast and website represent the opinions of Dr. Shawn Tassone and his guests. The content here should not be taken as medical advice and is for informational purposes only. Because each person is so unique, please consult your health care professional for any medical questions.
Despite gains in recent years, Black, Hispanic, and Asian communities are still under-represented in the U.S. nursing workforce. We're going to explore that gap and how to close it on this episode of Raise the Line from Elsevier with Dr. Ernest Grant, Vice Dean for Diversity, Equity, Inclusion and Belonging at the Duke University School of Nursing. "You get a patient who is more compliant when they see someone who looks like them, who is from their culture and who can advocate on their behalf," he tells host Lindsey Smith. Dr. Grant bases that and other insights on a rich professional background that includes 50 years in nursing, being a leading advocate for his profession and breaking down barriers himself as a male nurse of color and the first man elected president of the American Nurses Association. In this thoughtful conversation, Dr. Grant reflects on what it took to earn credibility in leadership roles, how he's navigating the political climate on DEI initiatives, and the causes and solutions to the persistent shortage in nursing faculty, among other pressing issues. Tune in for a uniquely-informed look at what it will take to build a stronger, more representative nursing profession. Mentioned in this episode: Duke University School of Nursing American Nurses Association If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast
This week, we feature new research on acute respiratory failure, wheezing in childhood, lung cancer, and obesity. We review myeloproliferative neoplasms and follow a diagnostic case of a patient with myasthenia gravis who developed dyspnea and weakness. Perspectives explore medical marijuana research, AI in clinical care, sexual and gender minority health research, and the Perspectives Editor saying goodbye.
Rebecca Haffajee is a professor in the Department of Health Policy and Management at the Yale School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. R.L. Haffajee, R.A. Mikos, and Z.D. Cooper. Marijuana Rescheduling — A Game Changer for Research? N Engl J Med 2026;395:729-731.
In this episode, 2 experts discuss the evolving role of weekly insulin therapy in modern type 2 diabetes (T2D) management. They share practical considerations for initiating or switching to these novel agents, including how to accurately convert daily doses, follow titration schedules, and support adherence and patient preferences through shared decision-making. Learn how you can ensure optimized glycemic control and reduced treatment burden in your patients with T2D by integrating weekly insulin therapies in your endocrinology, diabetology, or primary care practice. Presenters Richard E. Pratley, MD Samuel E. Crockett Chair in Diabetes Research Medical Director, AdventHealth Diabetes Institute Senior Investigator and Diabetes Program Lead AdventHealth Translational Research Institute Adjunct Professor of Medicine Johns Hopkins University School of Medicine Orlando, Florida Jay H. Shubrook, DO, FAAFP, FACOFP Professor, Diabetologist Department of Clinical Sciences and Community Medicine Touro University California, College of Osteopathic Medicine Vallejo, California Link to full program: https://bit.ly/4wyjOg7 Get access to all of our new podcasts by subscribing to the Decera Clinical Education Multispecialty Podcast on Apple Podcasts, YouTube Music, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
In this episode of SoundPractice, host Mike Sacopulos talks with veteran healthcare journalist Ken Terry about his new book, Beyond Medicare for All: Cracking the Code of the Healthcare Affordability Crisis, published by the American Association for Physician Leadership. Terry, a former senior editor at Medical Economics has written for publications including Medscape Medical News, WebMD, cio.com, InformationWeek, and Fierce Healthcare. He is the author of two previous books on healthcare reform, Rx for Health Care Reform (Vanderbilt University Press, 2007) and Physician-Led Healthcare Reform: A New Approach to Medicare For All (AAPL, 2020). He also contributed to Stephen K. Klasko's 2023 book, Feelin' Alright: How the Message in The Music Can Make Healthcare Healthier. In this interview, Terry explains why he abandoned the assumption that Medicare for All will ever become reality — and lays out an alternative model built around empowered, salaried primary care groups, all-payer hospital rates, and a new “consumer council” to help guide difficult coverage decisions. Topics Discussed: Why primary care physicians should lead basic care — and how that could reverse primary care's decline The role of physician assistants and nurse practitioners in a primary-care-led system How corporate practice of medicine laws could be strengthened, state by state, to give PCPs more independence Why insurers and hospitals might support this model rather than fight it Maryland's all-payer, global-budget hospital system as a template for reform A modified approach for rural healthcare, where physician scarcity changes the equation Caring for an aging population and the unresolved challenge of long-term care financing The idea of a “consumer council,” inspired by the late David Eddy, to help guide coverage decisions for new technologies What's next for Terry, including plans to bring these ideas to Congress and the 2028 presidential campaigns Learn more about the American Association for Physician Leadership. https://doi.org/10.55834/sp.9016618520
Join host Eve Cunningham, MD, Chief Medical Officer at Cadence, in conversation with Erica Stevens, DO, Vice President and Department Chair of Primary Care at Corewell Health West. Dr. Stevens leads a broad primary care portfolio spanning more than 650 physicians and advanced practice providers across family medicine, internal medicine, pediatrics, urgent care, palliative care, hospice, and several specialty services. In this episode, Drs. Eve and Erica explore what it takes to move chronic disease management from a reactive, office-based model to a more proactive and connected approach. Their conversation covers: Why primary care must evolve from “see you in three months” to continuous, proactive support How remote care can serve as a trusted extension of the physician and APP team What health systems should look for in a partner supporting chronic disease management How Corewell Health built clinician trust through pilots, feedback, data, and patient stories Why integration, shared protocols, and flexibility are essential to scaling team-based care What strong patient adoption reveals about the demand for support beyond the office visit How ongoing monitoring and education can help patients better manage medications, diet, and daily care What other health system leaders should know about moving from pilot to scale How digital tools, AI, and ambient technology could shape the future of primary care Dr. Stevens is a partner of Cadence and not compensated for this podcast.
Health care workforce shortages aren't experienced the same way in every community and deciding where to invest limited resources requires more than just counting clinicians. Steve Holloway, director of the Primary Care Office for the Colorado Department of Public Health and Environment, explains how his team uses data and geospatial analysis to identify communities with the greatest need for primary, oral and behavioral health providers. Holloway discusses the role of Health Professional Shortage Area designations, Colorado's state-specific approach to measuring access, and the Colorado Health Service Corps, which has supported hundreds of clinicians serving underserved communities. He also explains how partnerships with philanthropy have helped Colorado stretch public workforce investments further, directing resources toward communities where they can make the biggest difference.2026 Primary Care Office Annual Technical Assistance Assessment | ASTHOVoices From the Field: Public Health Success Stories | ASTHOUsing Data-Driven Strategy to Prevent ACEs and Improve Health Outcomes | ASTHOStrengthening Partnerships to Prevent Overdose: Key Actions in a Multi-State Learning Collaborative | ASTHORisk of Severe Arboviral Disease in Patients Receiving B Cell-Depleting or Modulating Medications | HAN | CDC
This week, we feature new research on polymyalgia rheumatica, hypercholesterolemia, prostate cancer, and multiple myeloma. We review evidence-based strategies for tobacco cessation, and follow a case of a woman with nausea, dizziness, and metabolic acidosis. We discuss recent advances in gene editing for rare metabolic diseases. Perspectives address HIV care, health care quality, medical ethics, and finding resilience in the face of serious illness.
There are few things more frustrating for an Emergency Physician than caring for patient after patient who lands in the ED not because it's necessarily the best place for their care, but because every other door in the health care system was closed, confusing or impossible to find. Emergency Medicine and Primary Care often operate in different worlds—one built around rapid diagnosis and uncertainty, the other around continuity and prevention—but our patients move constantly between the two. In this special EM Cases podcast, EM–Primary Care Health Systems Strategies, we step outside the usual ED lens with Dr. Tara Kiran (host of the Primary Focus podcast) and Dr. Danielle Martin to ask how we can deliver the right care, in the right place, at the right time. We challenge assumptions about what drives ED use and explore team-based primary care, after-hours cooperatives, call-first triage, virtual care, information sharing and warm handoffs. Drawing on models from Canada, the Netherlands, Denmark and elsewhere, we finish with practical strategies to reduce fragmentation, improve continuity and make the system work better for patients and providers. Please consider a donation to EM Cases to support our mission of providing high quality free open access medical education here: https://emergencymedicinecases.com/donation/. Disclaimer: This episode was recorded in October 2025, prior to Dr. Danielle Martin becoming a candidate for government office. The views and opinions expressed by Dr. Martin in this discussion were her own at the time of recording and do not represent or reflect the views, policies, or positions of the Government of Canada.
Some of the most serious diagnoses in pediatrics begin with common pediatric symptoms. A child comes in looking pale or with a febrile illness. They've been more tired than usual. Maybe they're bruising easily or complaining their legs hurt. Individually, none of these symptoms are unusual. Together, or with persistence, they can tell a different story. Leukemia is the most common childhood cancer, but it's earliest signs often resemble everyday illnesses. The episode introduces Ashley Rogers, MD, a pediatric oncologist at Children's Hospital Colorado and faculty member at the University of Colorado School of Medicine, as the newest host of Charting Pediatrics. As David Brumbaugh concludes his remarkable nine-year tenure as host, he passes the microphone to Dr. Rogers, ushering in the next chapter of the podcast. Dr. Rogers joins the conversation to share her expertise on childhood leukemia, including key considerations for diagnosis, treatment and the pediatrician's role in recognizing and managing these patients. This episode offers both valuable clinical insights and a warm welcome to a new voice who will continue bringing evidence-based pediatric education to listeners. Some highlights from this episode include: Earliest signs of leukemia pediatricians can look out for How to distinguish between viral illnesses or leukemia Red flags that shouldn't be dismissed Role of the pediatrician after a leukemia diagnosis For more information on Children's Colorado, visit: childrenscolorado.org.
© 2020-2026 Ivy Podcast Discovery LLC
